IO Biotech Q3 EPS $(0.43) Beats $(0.44) Estimate
Portfolio Pulse from Benzinga Newsdesk
IO Biotech (NASDAQ:IOBT) reported a Q3 EPS loss of $(0.43), slightly better than the analyst consensus estimate of $(0.44). This represents a 23.21% improvement from the $(0.56) per share loss reported in the same quarter of the previous year.
November 13, 2023 | 1:43 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
IO Biotech reported a smaller-than-expected quarterly loss and showed improvement compared to the previous year's same quarter.
Beating EPS estimates typically has a positive impact on investor sentiment, which can lead to a short-term increase in stock price. The improvement over the previous year's loss also indicates progress in the company's financial performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100